Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2Gastroesophageal Reflux 2Barrett Esophagus 2Zollinger-Ellison Syndrome 1Xerostomia 1Stomach Ulcer 1Pseudomyxoma Peritonei 1Oropharyngeal Neoplasms 1Mucositis 1Hemorrhage 1Helicobacter Infections 1Heartburn 1Head and Neck Neoplasms 1Gastritis, Atrophic 1Esophagitis, Peptic 1Appendiceal Neoplasms 1

Interventions

Enoxaparin 2Endoscopic Mucosal Resection 2Tranexamic Acid 1Tinzaparin 1Standard of Care 1Radiotherapy 1Proton Pump Inhibitors 1Pancreaticoduodenectomy 1Palliative Care 1Neuromuscular Blockade 1Lansoprazole 1Esomeprazole 1Data Collection 1Dalteparin 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemorrhage × Lansoprazole × Gastrointestinal × Clear all
NCT02150447 2018-04-04

The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding

National Cancer Center, Korea

Phase 3 Terminated
394 enrolled
Gastrointestinal

Hemorrhage, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡